PATHWAYS TO THE DIAGNOSIS OF PROSTATE CANCER IN THE CONTROL ARM OF A LARGE RANDOMISED SCREENING TRIAL
✍ Scribed by Gosselaar, C.; Roemeling, S.; Roobol, M.J.; Schröder, F.H.
- Book ID
- 122584160
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 55 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Prostate cancer (PC) mortality is the most valid end‐point in screening trials, but could be influenced by the choice of initial treatment if treatment has an effect on mortality. In this study, PC treatment was compared between the screening and control arms in a screening trial. Data
## Abstract We estimated the sensitivity of serum prostate‐specific antigen (PSA) as a screening test for prostate cancer in the Finnish randomised, population‐based prostate cancer screening trial. The study population consisted of 80,458 men aged 55–67 years identified from the national populatio